Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-139P is a human gene classified as a pseudogene related to the U6 small nuclear RNA family. U6 snRNA is a highly conserved non-coding RNA, integral to the function of the spliceosome and essential for excising introns from precursor mRNA in eukaryotes[3]. The U6 family is important for cell viability, and pseudogenes such as RNU6-139P represent genomic sequences that have lost their coding potential due to mutations and do not produce functional RNA or protein. Pseudogene-derived loci are common in the genome and are not considered canonical drug targets, nor do they have established roles in disease, drug interaction, or utility as biomarkers in current literature[5][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 139, pseudogene (RNU6-139P).